Today: 30 June 2026
Nvidia stock price slips before the bell as China weighs DeepSeek’s H200 chip buys
30 January 2026
2 mins read

Nvidia stock price slips before the bell as China weighs DeepSeek’s H200 chip buys

New York, Jan 30, 2026, 09:12 EST — Premarket

  • Nvidia shares slipped roughly 1.2% in U.S. premarket trading following a report on China’s conditional green light for H200 chip purchases.
  • Investors are keeping an eye on talks of a new OpenAI funding round, potentially involving Nvidia.
  • Nvidia’s earnings and guidance set for Feb. 25 are the next big catalyst.

Nvidia (NVDA.O) shares dipped 1.2% to $190.28 in premarket, pulling back from Thursday’s close of $192.51, which was up 0.5%.

The move came after a Reuters report revealed that China has granted its leading AI startup DeepSeek conditional approval to purchase Nvidia’s H200 artificial-intelligence chips, though regulatory details are still being worked out.

For Nvidia, the stakes are high with the H200 — a top-tier AI chip — now serving as a real-time gauge of how fast shipments to Chinese customers can pick up amid changing regulations and political tension across the Pacific. Traders are keenly awaiting signs that approvals will translate into actual orders and shipments, not just red tape delays.

Nvidia Chief Executive Jensen Huang said on Thursday that the licence process is still being finalised and that China “has to decide,” adding he was “looking forward to a favourable decision.” Reuters

The downside case is also fueled by the same tug-of-war: a senior U.S. lawmaker claimed Nvidia gave technical help that boosted DeepSeek’s training efficiency. The worry is whether advanced chips and expertise might aid military use despite existing restrictions. The letter from the lawmaker specifically mentioned “GPU hours”—a basic metric for how long chips run to train an AI model. Reuters

Investors are also weighing new chatter about OpenAI’s funding, which often affects chipmakers due to the implied demand and the cash needed to cover it. According to a source quoted by Reuters, Amazon is in early discussions to pour up to $50 billion into OpenAI. Meanwhile, an Information report cited by Reuters says Nvidia, Amazon, and Microsoft are negotiating investments that could total as much as $60 billion.

OpenAI’s moves coincide with Big Tech and key investors scrambling to secure compute power and partnerships, while the company pours significant funds into data centers. Reuters reports OpenAI aims to raise as much as $100 billion, targeting a valuation near $830 billion, with plans underway for an IPO that could push its value to $1 trillion.

Markets started cautiously after President Donald Trump named Kevin Warsh as his nominee for the next Federal Reserve chair. The announcement lifted the dollar and introduced fresh uncertainty for rate-sensitive growth stocks. “It’s one thing to appoint somebody and it’s entirely different to actually be Chairman of the Federal Reserve,” said Chris Beauchamp, chief market analyst at IG Markets. Reuters

Nvidia followed the surge in big-cap tech and chip stocks this week. The share price climbed 1.8% on Jan. 28, buoyed by gains in chip names that helped lift U.S. indexes ahead of the Fed announcement and earnings from major tech players.

Nvidia is set to report its fourth-quarter and fiscal-year results on Feb. 25. Investors will be keenly watching for updates on demand from China, ongoing supply chain issues, and how quickly AI infrastructure spending is ramping up.

The road ahead might remain volatile. Beijing’s regulations could tighten, U.S. political pressure might ramp up, and any lag in converting approvals into actual orders would dent short-term hopes pinned on China shipments.

At this stage, traders are focused on China’s final terms for H200 imports and if U.S. officials will reply. The larger, clearer trigger, though, is Nvidia’s earnings and guidance due Feb. 25.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • CELZ Jumps 252% as Creative Medical Technology Drops Equity Offer
    June 30, 2026, 12:50 PM EDT. Shares of Creative Medical Technology Holdings (NASDAQ:CELZ) shot up 252% Tuesday after the company pulled its June 25 S-1 for an equity and warrant deal. CELZ said it had not issued any shares under the canceled filing. Trading was heavy, hitting 146.1 million shares-almost 40 times its 3.7 million shares outstanding. The shelved offer would have meant 3.05 million new shares and warrants for another 6.09 million. CEO Timothy Warbington said they decided not to go ahead with the fundraising plan. Biotech ETFs didn't move much, pointing to a CELZ-specific jump. Still, analysts say cash remains tight, with limited room for rounds of regulatory approvals after December 2027.
C3.ai stock price slips in premarket as Automation Anywhere merger-talk report lingers
Previous Story

C3.ai stock price slips in premarket as Automation Anywhere merger-talk report lingers

Reckitt Benckiser shares jump, but an ex-dividend reset looms on Monday
Next Story

Reckitt Benckiser shares jump, but an ex-dividend reset looms on Monday

Go toTop